Search research articles
Contact Us
Filters
Showing results (1-10 of 59) with videos related to
Page
of 6
Sort By:
Epigenomics
|
January 17, 2022
Cell-free DNA methylation as a potential biomarker in brain disorders
Yulin Jin, Emily G Allen, Peng Jin
Molecular Psychiatry
|
April 27, 2022
Epitranscriptomic dynamics in brain development and disease
Andrew M Shafik, Emily G Allen, Peng Jin
Epigenomics
|
February 22, 2020
Dynamic N6-methyladenosine RNA methylation in brain and diseases
Andrew M Shafik, Emily G Allen, Peng Jin
Frontiers in Cellular Neuroscience
|
May 31, 2021
Therapeutic Development for CGG Repeat Expansion-Associated Neurodegeneration
Keqin Xu, Yujing Li, Emily G Allen, et al.
Human Molecular Genetics
|
July 27, 2019
Diverse and dynamic DNA modifications in brain and diseases
Matthew J Armstrong, Yulin Jin, Emily G Allen, et al.
Human Genetics
|
February 6, 2004
A study of the distributional characteristics of FMR1 transcript levels in 238 individuals
Emily G Allen, Weiya He, Maneesha Yadav-Shah, et al.
Frontiers in Molecular Biosciences
|
November 16, 2020
Metabolic Alterations in <i>FMR1</i> Premutation Carriers
Yiqu Cao, Yun Peng, Ha Eun Kong, et al.
Mental Retardation and Developmental Disabilities Research Reviews
|
October 3, 2007
Epidemiology of Down syndrome
Stephanie L Sherman, Emily G Allen, Lora H Bean, et al.
Journal of Assisted Reproduction and Genetics
|
December 6, 2024
Women's healthcare providers' knowledge and practices surrounding fragile-X associated primary ovarian insufficiency (FXPOI)
Alexandra L Singleton, Heather S Hipp, Nadia Ali, et al.
Frontiers in Genetics
|
August 23, 2014
Approaches to identify genetic variants that influence the risk for onset of fragile X-associated primary ovarian insufficiency (FXPOI): a preliminary study
Emily G Allen, Wendy E Grus, Sarayu Narayan, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 59) with videos related to
Sort By:
Page
of 6
Epigenomics
|
January 17, 2022
Cell-free DNA methylation as a potential biomarker in brain disorders
Yulin Jin, Emily G Allen, Peng Jin
Molecular Psychiatry
|
April 27, 2022
Epitranscriptomic dynamics in brain development and disease
Andrew M Shafik, Emily G Allen, Peng Jin
Epigenomics
|
February 22, 2020
Dynamic N6-methyladenosine RNA methylation in brain and diseases
Andrew M Shafik, Emily G Allen, Peng Jin
Frontiers in Cellular Neuroscience
|
May 31, 2021
Therapeutic Development for CGG Repeat Expansion-Associated Neurodegeneration
Keqin Xu, Yujing Li, Emily G Allen, et al.
Human Molecular Genetics
|
July 27, 2019
Diverse and dynamic DNA modifications in brain and diseases
Matthew J Armstrong, Yulin Jin, Emily G Allen, et al.
Human Genetics
|
February 6, 2004
A study of the distributional characteristics of FMR1 transcript levels in 238 individuals
Emily G Allen, Weiya He, Maneesha Yadav-Shah, et al.
Frontiers in Molecular Biosciences
|
November 16, 2020
Metabolic Alterations in <i>FMR1</i> Premutation Carriers
Yiqu Cao, Yun Peng, Ha Eun Kong, et al.
Mental Retardation and Developmental Disabilities Research Reviews
|
October 3, 2007
Epidemiology of Down syndrome
Stephanie L Sherman, Emily G Allen, Lora H Bean, et al.
Journal of Assisted Reproduction and Genetics
|
December 6, 2024
Women's healthcare providers' knowledge and practices surrounding fragile-X associated primary ovarian insufficiency (FXPOI)
Alexandra L Singleton, Heather S Hipp, Nadia Ali, et al.
Frontiers in Genetics
|
August 23, 2014
Approaches to identify genetic variants that influence the risk for onset of fragile X-associated primary ovarian insufficiency (FXPOI): a preliminary study
Emily G Allen, Wendy E Grus, Sarayu Narayan, et al.
Page
of 6